SMS Pharmaceuticals Limited (SMSPHARMA.NS)
INR 241.75
(1.64%)
INR 241.75
(1.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 7.09 Billion | 5.22 Billion | 5.15 Billion | 5.6 Billion | 4.07 Billion | 4.61 Billion |
| Cost of Revenue | 4.98 Billion | 3.93 Billion | 3.33 Billion | 3.79 Billion | 2.79 Billion | 3.27 Billion |
| Gross Profit | 2.1 Billion | 1.28 Billion | 1.81 Billion | 1.81 Billion | 1.27 Billion | 1.34 Billion |
| Operating Expenses | 769.2 Million | 1.06 Billion | 989.6 Million | 825.61 Million | 693.36 Million | 633.99 Million |
| Selling, General and Administrative Expenses | 658.07 Million | 94.1 Million | 83.68 Million | 91.96 Million | 64.97 Million | 45.04 Million |
| Research and Development Expenses | 111.13 Million | 89.19 Million | 83.93 Million | 73.48 Million | 74.38 Million | 70.43 Million |
| Other Expenses | - | 48.85 Million | 20.58 Million | 25.68 Million | 29.65 Million | 20.81 Million |
| Cost and Expenses | 5.75 Billion | 4.99 Billion | 4.32 Billion | 4.61 Billion | 3.49 Billion | 3.9 Billion |
| Operating Income | 1.34 Billion | 272.64 Million | 821.76 Million | 988.63 Million | 580.09 Million | 708.73 Million |
| Interest Expense | 234.56 Million | 219.15 Million | 181.56 Million | 102.53 Million | 111.93 Million | 114.19 Million |
| Income Tax Expense | 169.06 Million | 14.65 Million | 6.18 Million | 301.55 Million | 180.67 Million | 209 Million |
| Earnings before Tax | 661.06 Million | 53.49 Million | 684.99 Million | 911.19 Million | 507.55 Million | 623.54 Million |
| Net Income | 498.26 Million | -70.59 Million | 622.19 Million | 625.26 Million | 315.73 Million | 400.48 Million |
| Earnings Per Share Basic | 5.89 | -0.83 | 7.35 | 7.39 | 3.73 | 4.73 |
| Earnings Per Share Diluted | 5.89 | -0.83 | 7.35 | 7.39 | 3.73 | 4.73 |
| Weighted Average Shares Outstanding | 84.59 Million | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million |
| Gross Margin | 0.30 | 0.25 | 0.35 | 0.32 | 0.31 | 0.29 |
| EBIT Margin | 0.17 | 0.11 | 0.23 | 0.22 | 0.21 | 0.20 |
| Profit Margin | 0.07 | -0.01 | 0.12 | 0.11 | 0.08 | 0.09 |
| EBITDA | 1.21 Billion | 593.89 Million | 1.19 Billion | 1.24 Billion | 850.33 Million | 935 Million |
| Earnings Before Tax Margin | 0.19 | 0.05 | 0.16 | 0.18 | 0.14 | 0.15 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.64 Billion | 7.09 Billion | 2.45 Billion | 1.61 Billion | 1.66 Billion | 1.35 Billion |
| Cost of Revenue | 1.31 Billion | 5.93 Billion | 2.1 Billion | 1.1 Billion | 1.16 Billion | 878.78 Million |
| Gross Profit | 330.27 Million | 1.15 Billion | 352.11 Million | 507.04 Million | 501.4 Million | 474.6 Million |
| Operating Expenses | 78.97 Million | 307.86 Million | 95.1 Million | 297.15 Million | 302.19 Million | 289.68 Million |
| Selling, General and Administrative Expenses | 78.97 Million | - | 95.1 Million | 76.9 Million | 86.73 Million | 77.23 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 13.67 Million | 44.59 Million | 16.45 Million | 14.9 Million | 8.1 Million | 5.12 Million |
| Cost and Expenses | 1.39 Billion | 6.24 Billion | 2.2 Billion | 1.4 Billion | 1.46 Billion | 1.16 Billion |
| Operating Income | 251.29 Million | 851.03 Million | 257.01 Million | 224.79 Million | 207.31 Million | 190.05 Million |
| Interest Expense | 46.67 Million | 234.56 Million | 56.09 Million | 59.52 Million | 55.72 Million | 63.22 Million |
| Income Tax Expense | 54.55 Million | 169.06 Million | 56.85 Million | 42.35 Million | 31.12 Million | 38.73 Million |
| Earnings before Tax | 218.3 Million | 661.06 Million | 217.37 Million | 165.27 Million | 151.59 Million | 126.82 Million |
| Net Income | 164.79 Million | 498.26 Million | 172.78 Million | 114.8 Million | 117.25 Million | 93.41 Million |
| Earnings Per Share Basic | 1.95 | - | 2.04 | 1.36 | 1.39 | 1.10 |
| Earnings Per Share Diluted | 1.95 | - | 2.04 | 1.36 | 1.39 | 1.10 |
| Weighted Average Shares Outstanding | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million | 84.65 Million |
| Gross Margin | 0.20 | 0.16 | 0.14 | 0.31 | 0.30 | 0.35 |
| EBIT Margin | 0.20 | - | 0.14 | 0.19 | 0.17 | 0.20 |
| Profit Margin | 0.10 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| EBITDA | 335.11 Million | - | 336.17 Million | 304.88 Million | 286.31 Million | 266.96 Million |
| Earnings Before Tax Margin | 0.15 | 0.12 | 0.10 | 0.14 | 0.12 | 0.14 |
002255
QGLDF
ANKOF
FCAP
INL
SOLB